Altimmune Inc (ALT)

Altimmune Inc Stock (ALT) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
	8.19%26.23	24.24	28.92	20.86	22.93
Research and Development	15.21%18.66	16.19	18.41	14.96	17.24
Operating Income/Loss	8.19%-26.23	-24.24	-28.89	-20.86	-22.92
Nonoperating Income/Loss	102.50%3.40	1.68	1.54	1.85	0.78
Income/Loss From Continuing Operations Before Tax	1.16%-22.83	-22.56	-27.36	-19.01	-22.15
	1.16%-22.83	-22.56	-27.36	-19.01	-22.15
Attributable To Parent	1.16%-22.83	-22.56	-27.36	-19.01	-22.15
Basic Average Shares	49.00%185.44	124.46	5.91	89.42	81.48
Diluted Average Shares	49.00%185.44	124.46	5.91	89.42	81.48
Basic Earnings Per Share	33.33%-0.12	-0.18	-0.26	-0.21	-0.27
Diluted Earnings Per Share	33.33%-0.12	-0.18	-0.26	-0.21	-0.27